(Australia-NewsWire.Com, September 26, 2017 ) According to the report Asia Pacific Protein Labelling Market By Product (Reagents, Kits And Services), Labelling Method (In Vitro Labelling, In Vivo Labelling), Application (Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique, Protein Microarray), End Users & Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (20162021) published by Market Data Forecast, The Asia Pacific Protein Labelling Market was worth USD 0.2 billion in 2016 and estimated to be growing at a CAGR of 14.52%, to reach USD 0.38 billion by 2021.
Protein labelling is done using labelling reagents and kits to label an antibody or other protein, to make an enzyme conjugate, fluorescent probe, biotinylated binding reagent or iodine-labelled tracer for detecting proteins in tissues, cells, and biochemical assays.
Protein labelling methods includes in-Vivo and in-Vitro labelling technique. These techniques are based genetic engineering which includes improved high sensitivity and imaging technology. Snap-tag and halo-tag are widely used technology in in-vivo and in-vitro labelling. Halo-tag and snap-tag are a significant tool for functional protein analysis based on the formation of covalent bond between protein fusion tag and synthetic chemical ligand. These tools enable to explore proteomics and genomics in the more profound way with high affinity and specificity to determine disease state.
Improved healthcare spending, healthcare expenditure, rising R&D spending, and increasing proteomics research, infrastructure development and favorable government policies, Cell culture based experiments, rise in adoption of personalized medicines, the growth of flow Cytometry and tissue diagnostics is expected to create significant demand for Asia Pacific protein labelling. In addition, growing proteomics research is bolstering the market growth. However, lack of skilled professionals, lack of awareness and high costs of products is the restrains hindering the Asia Pacific Protein Labelling Market growth.
The Asia Pacific Protein Labelling market is categorized by Product, Labelling method, Application and End users. On the basis of Product, the market is segmented into Reagents, Kits and Services. The Labelling segment includes In vitro Labelling and In vivo Labelling. On the basis of Application, the market is further segmented into Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique and Protein Microarray. The Asia Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia Pacific region is expected to be the fastest growing segment with a global share of 16% and has a CAGR of 14.52% due to the increased demands of emerging economies such as Japan and China, growing demographics and rise in healthcare expenditure.
The Key companies dominating the Asia Pacific protein labelling market are: Thermo Fisher Scientific, Inc. General Electric Company Merck KGaA Eurogentec S.A. PerkinElmer, Inc. F. Hoffmann-La Roche AG New England Biolabs Kaneka Corporation Kirkegaard & Perry Laboratories Promega Corporation LI-COR, Inc. SeraCare Life Sciences, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
Media Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast www.marketdataforecast.com Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/